First published online 29 June 2004
doi: 10.1242/jcs.01222
Journal of Cell Science 117, 3539-3545 (2004)
Published by The Company of Biologists 2004
CD133, a novel marker for human prostatic epithelial stem cells
Gavin D. Richardson1,
Craig N. Robson1,
Shona H. Lang2,
David E. Neal3,
Norman J. Maitland2 and
Anne T. Collins2,*
1 Prostate Research Group, Surgical Oncology, Medical School, Framlington Place, University of Newcastle upon Tyne, Newcastle upon Tyne, NE2 4HH, UK
2 YCR Cancer Research Unit (Area 13), Department of Biology, University of York, PO BOX 373, York, YO10 5DD, UK
3 Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Cambridge, CB2 2QQ, UK

View larger version (115K):
[in a new window]
|
Fig. 1. A rare sub-set of basal cells express CD133+. A paraffin section of prostatic acini labelled with the nuclear stain DAPI (blue) and anti-CD133 directly conjugated to PE (red). 200 cross sections of acini were studied by confocal microscopy for the presence and location of CD133+ cells. Scale bar: 40 µm.
|
|

View larger version (127K):
[in a new window]
|
Fig. 5. CD133+ selected cells form fully differentiated acini in immunocompromised mice. Xenografts of prostate acini formed by transplantation of 2ß1hi/CD133+ basal cells stained with (A) Haematoxylin and Eosin, (B) 34ßE12, (C) anti-K18, (D) anti-PAP (E) Anti-androgen receptor. Scale bar: 40 µm.
|
|
© The Company of Biologists Ltd 2004